Long-Term Debt (Quarterly)

Long-Term Debt: The sum of all long term debt fields.

Swedish Orphan Biovitrum (BIOVF) had Long-Term Debt of $837.24M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$785.93M
Net Income	$144.19M
Cost of Goods Sold	$191.12M
Gross Profit	$594.81M
Operating Expenses	$581.68M
Operating Income	$204.25M
Non-Operating Income/Expense	$-20.46M
Pre-Tax Income	$183.90M
Normalized Pre-Tax Income	$183.90M
Income after Taxes	$144.19M
Income from Continuous Operations	$144.19M
Consolidated Net Income/Loss	$144.19M
Normalized Income after Taxes	$144.19M
EBIT	$204.25M
EBITDA	$289.80M
Weighted-Average Shares Outstanding (Basic)	345.94M
Weighted-Average Shares Outstanding (Diluted)	349.63M
Earnings per Share (EPS) (Basic)	$0.42
Earnings per Share (EPS) (Diluted)	$0.41
Balance Sheet Financials
Current Assets	$1.67B
Property, Plant, and Equipment	$178.76M
Long-Term Assets	$7.22B
Total Assets	$8.89B
Current Liabilities	$2.37B
Long-Term Debt	$837.24M
Long-Term Liabilities	$2.10B
Total Liabilities	$4.47B
Common Equity	$4.42B
Tangible Shareholders Equity	$-2.35B
Shareholders Equity	$4.42B
Common Shares Outstanding	345.85M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$123.18M
Cash Flow from Investing Activities	$-956.81M
Cash Flow from Financial Activities	$820.72M
Beginning Cash	$113.89M
End Cash	$102.84M
Increase/Decrease in Cash	$-11.05M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.70
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.46
Gross Margin	75.68%
Operating Margin	25.99%
EBIT Margin	25.99%
EBITDA Margin	--
Pre-Tax Profit Margin	23.40%
Profit Margin	18.35%
Free Cash Flow	$122.86M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.34
Receiveable Turnover	0.77
Days Sales in Receivables	116.22
Return on Equity	3.26%
Return on Tangible Equity	-6.14%
Return on Assets	1.62%
Return on Investments	2.74%
Book Value Per Share	$12.77
Free Cash Flow per Share	$0.35
Operating Cash Flow per Share	$0.35

Data from Zacks Investment Research, Inc.